Pee Cee Cosma Sope Share Price
Sector: Personal & Household Prods.
673.00 +46.05 (7.35%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
610.20
Today’s High
710.00
52 Week Low
383.89
52 Week High
978.60
Key Metrics
- Market Cap (In Cr) 177.52
- Beta 0.17
- Div. Yield (%) 0.45
- P/B 4.39
- TTM P/E 13.37
- Peg Ratio 0.51
- Sector P/E 0
- Open Price 626.95
- Prev Close 626.95
Pee Cee Cosma Sope Analysis
Price Analysis
-
1 Week15.17%
-
3 Months15.2%
-
6 Month-5.2%
-
YTD13.2%
-
1 Year55.19%
Risk Meter
- 44% Low risk
- 44% Moderate risk
- 44% Balanced Risk
- 44% High risk
- 44% Extreme risk
Pee Cee Cosma Sope Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 133.64
- Selling/ General/ Admin Expenses Total
- 10.6
- Depreciation/ Amortization
- 1.6
- Other Operating Expenses Total
- 16.61
- Total Operating Expense
- 119.89
- Operating Income
- 13.75
- Net Income Before Taxes
- 14.05
- Net Income
- 10.44
- Diluted Normalized EPS
- 39.89
- Period
- 2024
- Total Assets
- 48.3
- Total Liabilities
- 8.02
- Total Equity
- 40.28
- Tangible Book Valueper Share Common Eq
- 152.23
- Period
- 2024
- Cashfrom Operating Activities
- 6.09
- Cashfrom Investing Activities
- -1.04
- Cashfrom Financing Activities
- -5.06
- Net Changein Cash
- -0.01
- Period
- 2023
- Total Revenue
- 124.52
- Selling/ General/ Admin Expenses Total
- 9.82
- Depreciation/ Amortization
- 1.51
- Other Operating Expenses Total
- 14.73
- Total Operating Expense
- 120.84
- Operating Income
- 3.67
- Net Income Before Taxes
- 3.33
- Net Income
- 2.49
- Diluted Normalized EPS
- 9.59
- Period
- 2023
- Total Assets
- 46.75
- Total Liabilities
- 16.38
- Total Equity
- 30.37
- Tangible Book Valueper Share Common Eq
- 114.76
- Period
- 2023
- Cashfrom Operating Activities
- 3.39
- Cashfrom Investing Activities
- -0.93
- Cashfrom Financing Activities
- -3.71
- Net Changein Cash
- -1.26
- Period
- 2022
- Total Revenue
- 92.69
- Selling/ General/ Admin Expenses Total
- 8.88
- Depreciation/ Amortization
- 0.66
- Other Operating Expenses Total
- 10.88
- Total Operating Expense
- 90.55
- Operating Income
- 2.14
- Net Income Before Taxes
- 2.29
- Net Income
- 1.69
- Diluted Normalized EPS
- 6.37
- Period
- 2022
- Total Assets
- 47.27
- Total Liabilities
- 19.12
- Total Equity
- 28.15
- Tangible Book Valueper Share Common Eq
- 106.35
- Period
- 2022
- Cashfrom Operating Activities
- 8.82
- Cashfrom Investing Activities
- -10.6
- Cashfrom Financing Activities
- 3.04
- Net Changein Cash
- 1.26
- Period
- 2021
- Total Revenue
- 82.25
- Selling/ General/ Admin Expenses Total
- 8.23
- Depreciation/ Amortization
- 0.59
- Other Operating Expenses Total
- 8.47
- Total Operating Expense
- 76.16
- Operating Income
- 6.1
- Net Income Before Taxes
- 6.44
- Net Income
- 4.77
- Diluted Normalized EPS
- 18.01
- Period
- 2021
- Total Assets
- 35.91
- Total Liabilities
- 8.65
- Total Equity
- 27.26
- Tangible Book Valueper Share Common Eq
- 102.96
- Period
- 2021
- Cashfrom Operating Activities
- 0.03
- Cashfrom Investing Activities
- -0.48
- Cashfrom Financing Activities
- -1.64
- Net Changein Cash
- -2.08
- Period
- 2020
- Total Revenue
- 73.96
- Selling/ General/ Admin Expenses Total
- 8.63
- Depreciation/ Amortization
- 0.75
- Other Operating Expenses Total
- 9.53
- Total Operating Expense
- 71.21
- Operating Income
- 2.75
- Net Income Before Taxes
- 2.87
- Net Income
- 2.11
- Diluted Normalized EPS
- 7.88
- Period
- 2020
- Total Assets
- 32.07
- Total Liabilities
- 9.58
- Total Equity
- 22.49
- Tangible Book Valueper Share Common Eq
- 84.92
- Period
- 2020
- Cashfrom Operating Activities
- 3.25
- Cashfrom Investing Activities
- -0.68
- Cashfrom Financing Activities
- -0.62
- Net Changein Cash
- 1.96
- Period
- 2019
- Total Revenue
- 76.08
- Selling/ General/ Admin Expenses Total
- 8.02
- Depreciation/ Amortization
- 0.59
- Other Operating Expenses Total
- 9.3
- Total Operating Expense
- 72
- Operating Income
- 4.08
- Net Income Before Taxes
- 4.05
- Net Income
- 2.84
- Diluted Normalized EPS
- 10.72
- Period
- 2019
- Total Assets
- 29.51
- Total Liabilities
- 7.2
- Total Equity
- 22.31
- Tangible Book Valueper Share Common Eq
- 84.18
- Period
- 2019
- Cashfrom Operating Activities
- 1.13
- Cashfrom Investing Activities
- -0.46
- Cashfrom Financing Activities
- -0.61
- Net Changein Cash
- 0.05
- Period
- 2024-12-31
- Total Revenue
- 34.31
- Selling/ General/ Admin Expenses Total
- 2.94
- Depreciation/ Amortization
- 0.41
- Other Operating Expenses Total
- 4.04
- Total Operating Expense
- 30.5
- Operating Income
- 3.81
- Net Income Before Taxes
- 3.93
- Net Income
- 2.95
- Diluted Normalized EPS
- 11.1
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 30.94
- Selling/ General/ Admin Expenses Total
- 2.77
- Depreciation/ Amortization
- 0.39
- Other Operating Expenses Total
- 3.67
- Total Operating Expense
- 28.18
- Operating Income
- 2.76
- Net Income Before Taxes
- 3.54
- Net Income
- 2.66
- Diluted Normalized EPS
- 10.1
- Period
- 2024-09-30
- Total Assets
- 59.04
- Total Liabilities
- 12.74
- Total Equity
- 46.3
- Tangible Book Valueper Share Common Eq
- 174.95
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -0.21
- Cashfrom Investing Activities
- -0.51
- Cashfrom Financing Activities
- 3.22
- Net Changein Cash
- 2.51
- Period
- 2024-06-30
- Total Revenue
- 39.85
- Selling/ General/ Admin Expenses Total
- 2.71
- Depreciation/ Amortization
- 0.33
- Other Operating Expenses Total
- 4.21
- Total Operating Expense
- 36.01
- Operating Income
- 3.84
- Net Income Before Taxes
- 4.52
- Net Income
- 3.35
- Diluted Normalized EPS
- 12.7
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 30.54
- Selling/ General/ Admin Expenses Total
- 2.64
- Depreciation/ Amortization
- 0.43
- Other Operating Expenses Total
- 2.24
- Total Operating Expense
- 27.07
- Operating Income
- 3.47
- Net Income Before Taxes
- 3.66
- Net Income
- 2.71
- Diluted Normalized EPS
- 10.27
- Period
- 2024-03-31
- Total Assets
- 48.3
- Total Liabilities
- 8.02
- Total Equity
- 40.28
- Tangible Book Valueper Share Common Eq
- 152.23
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 6.09
- Cashfrom Investing Activities
- -1.04
- Cashfrom Financing Activities
- -5.06
- Net Changein Cash
- -0.01
- Period
- 2023-12-31
- Total Revenue
- 33.8
- Selling/ General/ Admin Expenses Total
- 2.71
- Depreciation/ Amortization
- 0.41
- Other Operating Expenses Total
- 4.55
- Total Operating Expense
- 30.14
- Operating Income
- 3.65
- Net Income Before Taxes
- 3.74
- Net Income
- 2.79
- Diluted Normalized EPS
- 10.6
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Pee Cee Cosma Sope Technical
Moving Average
SMA
- 5 Day589.41
- 10 Day573.82
- 20 Day571.42
- 50 Day564.62
- 100 Day580.42
- 300 Day619.51
Pee Cee Cosma Sope Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Radix Industries India
- 180.6
- 0.25
- 0.14
- 212
- 125.55
- 280.84
- Prime Fresh
- 155
- -2.95
- -1.87
- 254
- 106.35
- 211.5
- Pee Cee Cosma Sope
- 673
- 46.05
- 7.35
- 978.6
- 383.89
- 177.52
- Arunjyoti Bio Ventures
- 8.25
- 0.04
- 0.49
- 20.96
- 6.19
- 153.77
- Jhs Svendgaard Laboratories
- 14.75
- -0.77
- -4.96
- 32.9
- 11.12
- 126.27
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Radix Industries India
- 121.11
- 14.27
- 8.88
- 6.41
- Prime Fresh
- 30.93
- 3.47
- 16.39
- 4.43
- Pee Cee Cosma Sope
- 15.72
- 4.12
- 15.4
- 4.24
- Arunjyoti Bio Ventures
- -
- 9.62
- 1.06
- 0.27
- Jhs Svendgaard Laboratories
- -
- 0.71
- -2.71
- -5.81
Pee Cee Cosma Sope Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 19-May-25
- Audited Results & Final Dividend
- 13-Feb-25
- Quarterly Results
- 11-Nov-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results & A.G.M.
- 28-May-24
- Audited Results & Final Dividend
- 10-Feb-24
- Quarterly Results
- 04-Nov-23
- Quarterly Results
- 08-Aug-23
- Quarterly Results & A.G.M.
- 27-May-23
- Audited Results & Final Dividend
- 14-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 30-Sept-24
- 14-Aug-24
- AGM
- 29-Sept-23
- 07-Sept-23
- AGM
- -
- 12-Aug-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 28-May-24
- -
- 20-Sept-24
- 3
- 29-May-24
- -
- 20-Sept-24
- 2
- 29-May-23
- -
- 21-Sept-23
- 2
- 25-May-22
- -
- 16-Sept-22
- 1
- 25-Jun-21
- -
- 21-Sept-21
- 3


